Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Emergent BioSolutions Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry-Forward Securities
| Security Type |
Security Class Title |
Fee Rule |
Amount Registered(1) |
Proposed Price Per |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
Carry Forward Form Type |
Carry File |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Secondary Offering | ||||||||||||||||||||||||
| Fees to be Paid |
Equity | Common stock, $0.001 par value per share (“Common Stock”)(2) |
457(c) | 1,113,338 | $8.87(3) | $9,875,308.06(3) | 0.00015310 | $1,512.00 | — | — | — | — | ||||||||||||
| Fees to be Paid |
Equity | Common Stock underlying Series I Warrants(4) |
457(g) | 1,000,000 | $9.8802(5) | $9,880,200(5) | 0.00015310 | $1,512.66 | — | — | — | — | ||||||||||||
| Fees to be Paid |
Equity | Common Stock underlying Series II Warrants(6) |
457(g) | 1,500,000 | $15.7185(5) | $23,577,750(5) | 0.00015310 | $3,609.76 | — | — | — | — | ||||||||||||
| Fees to be Paid |
Equity | Series I Warrants | 457(g) | 1,000,000 | $9.8802(5) | — | 0.00015310 | — (7) | — | — | — | — | ||||||||||||
| Fees to be Paid |
Equity | Series II Warrants | 457(g) | 1,500,000 | $15.7185(5) | — | 0.00015310 | — (7) | — | — | — | — | ||||||||||||
| Fees Previously Paid |
— | |||||||||||||||||||||||
| Total Offering Amount | $43,333,258.06 | 0.00015310 | $6,634.42 | |||||||||||||||||||||
| Total Fees Previously Paid | $6,634.42(8) | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | — | |||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the registrant’s Common Stock that become issuable in respect of such securities by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Represents shares of Common Stock offered for resale by the holders thereof. |
| (3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, and based upon the average of the high and low prices of the registrant’s Common Stock as reported on The New York Stock Exchange on November 5, 2024, which was within five business days of the initial filing date of the Registration Statement. |
| (4) | Represents 1,000,000 shares of Common Stock issuable upon the exercise of warrants (the “Series I Warrants”) at an exercise price of $9.8802 per share. |
| (5) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, based on the applicable exercise price of the respective series of warrants. |
| (6) | Represents 1,500,000 shares of Common Stock issuable upon the exercise of warrants (the “Series II Warrants”) at an exercise price of $15.7185 per share. |
| (7) | No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act. |
| (8) | In connection with the initial filing of the Registration Statement on November 12, 2024, the registrant paid a filing fee of $6,634.42. No new securities are being registered on this post-effective amendment, so no filing fee is being transmitted herewith. |